Welcome to visit Zhongnan Medical Journal Press Series journal website!

Comparison and application of clinical practice guidlines and system re-view/Meta-analysis registration platforms

Published on Apr. 25, 2022Total Views: 12933 timesTotal Downloads: 3135 timesDownloadMobile

Author: Zi-Shuo MI 1 Jin GAO 2 Hao-Yang LI 3 Jian-Hua SUN 4, 5 Hao CHEN 5, 6

Affiliation: 1. College of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China 2. College of Traditional Chinese Medicine & Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China 3. First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China 4. Department of Accupuncture, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China 5. China Cen-ter for Evidence-Based Medicine Acupuncture Disease Project Team, Beijing 100700, China 6. College of Acupunc-ture and Tuina & College of Health and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing 210023, China

Keywords: Transparency Guideline Systematic review Meta analysis Registration platform

DOI: 10.12173/j.issn.1004-5511.202201029

Reference: Mi ZS, Gao J, Li HY, Sun JH, Chen H. Comparison and application of clinical practice guidlines and system review/Meta-analysis platforms[J]. Yixue Xinzhi Zazhi, 2022, 32(2): 90-98. DOI: 10.12173/j.issn.1004-5511.202201029.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

More attention is currently being paid to the concept of transparency in medical research. Research quality and transparency can be improved through research registration and public disclosure of the overview and specific information regarding a research program. At present, guidelines can be registered with Practice Guideline REgistration for transPAREncy (PREPARE), and the system review and Meta-analysis registration institutions include Cochrane Library, PROSPERO (International Prospective Register of Systematic Reviews), JBI (Joanna Briggs Institute) Library, Campbell, CEE (The Collaboration for Environmental Evidence) and the newly launched INPLASY (Interna-tional Platform of Registered Systematic Review and Meta-analysis Protocols). This paper introduces the basic infor-mation about the above platforms, as well as differences and similarities between those systematic re-view/Meta-analysis platforms in order to provide reference for interested researchers.

Full-text
Please download the PDF version to read the full text: download
References

1.Nosek BA, Alter G, Banks GC, et al. Scientific standards. Promoting an open research culture[J]. Science, 2015, 348(6242): 1422-1425. DOI: 10.1126/science.aab2374.

2.Straus S, Moher D. Registering systematic reviews[J]. CMAJ, 2010, 182(1): 13-14. DOI: 10.1503/cmaj.081849.

3.Mcnutt M. Reproducibility[J]. Science, 2014, 343(6168): 229.  DOI: 10.1126/science.1250475.

4.陈耀龙. 推动指南注册提升医疗质量 [N]. 健康报, 2021-03-31, (5). http://faxing.jkb.com.cn/home/index/menu.html?goods=1&item=780464&page=1387877922&name=jkb.

5.Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense[J]. Syst Rev, 2012, 1: 7. DOI: 10.1186/2046-4053-1-7.

6.陈耀龙, 杨克虎, 田金徽, 等. 循证实践指南的制定:国际经验与中国实践 [J]. 兰州大学学报(医学版), 2016, 42(1): 29-35. [Chen YL, Yang KH, Tian JH, et al. Development of evidence-based practice guidelines: international experience and Chinese practice[J]. Journal of Lanzhou University (Medical Sciences), 2016, 42(1): 29-35.] DOI: 10.13885/j.issn.1000-2812.2016.01.006.

7.杨智荣, 詹思延. PROSPERO:为非Cochrane系统评价全新打造的注册平台[J]. 中华医学杂志, 2012, 92(6): 422-425. [Yang ZR, Zhan SY. PROSPERO: a new registration platform for non-Cochrane systematic reviews[J]. National Medical Journal of China, 2012, 92(6): 422-425.] DOI: 10.3760/cma.j.issn.0376-2491.2012.06.018.

8.李慧, 陈耀龙, 王琪, 等. 中医(中西医结合)临床实践指南制修订方法——计划与注册[J]. 中华中医药杂志, 2016, 31(3): 903-906. [Li H, Chen YL, Wang Q, et al. Methodology on development and revision for Chinese medicine (integrative medicine)clinical practice guideline: plan and registration[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2016, 31(3): 903-906.] DOI: CNKI:SUN:BXYY.0.2016-03-044.

9.靳英辉, 段冬雪, 曾宪涛, 等. 临床实践指南制定方法——指南的注册与计划书设计与撰写[J]. 中国循证心血管医学杂志, 2018, 10(2): 129-132, 137. [Jin YH, Duan DX, Zeng XT, et al. Methodology for clinical practice guidelines: registration of guidelines and design and writ-ing of guideline proposal[J]. Chinese Journal of Evidence-Bases Cardiovascular Medicine, 2018, 10(2): 129-132, 137.] DOI: 10.3969/j.issn.1674-4055.2018.02.01.

10.方程, 邓巍, 樊景春, 等. 系统评价与Meta分析的注册平台简介[J]. 同济大学学报(医学版), 2019, 40(3): 380-387. [Fang C, Deng W, Fan JC, et al. Platforms for systematic review and meta-analysis registration: a briefly introduction[J]. Journal of Tongji University (Medi-cal Science), 2019, 40(3): 380-387.] DOI: 10.16118/j.1008-0392.2019.03.022.

11.雷军强, 杜亮, 王梦书, 等. 制定高质量循证诊断临床实践指南的方法与策略 [J]. 中国循证医学杂志, 2016, 16(1): 7-10. [Lei JQ, Du L, Wang MS, et al. Methods and strategies on how to improve the quality of diagnostic practice guideline in China[J]. Chinese Journal of Evidence-Based Medicine, 2016, 16(1): 7-10.] DOI: 10.7507/1672-2531.20160003.

12.罗杰, 冷卫东. 系统评价/Meta分析理论与实践[M]. 北京: 军事医学科学出版社, 2013. [Luo J, Leng WD. Theory&Practice of Systematic Review/Meta-Analysis[M]. Beijing: Military Medical Science Press, 2013.]

13.屈云, 何俐, 刘鸣. Cochrane系统评价的基本方法[J]. 中国临床康复, 2003, 7(4): 532-533, 536. [Qu Y, He L, Liu M. Basic review of meth-ods for Cochrane systematic review[J]. Chinese Journal of Clinical Rehabilitation, 2003, 7(4): 532-533, 536.] DOI: 10.3321/j.issn:1673-8225. 2003.04.003.

14.Davies S. The importance of PROSPERO to the National Institute for Health Research[J]. Syst Rev, 2012, 1: 5. DOI: 10.1186/2046-4053-1-5.

15.曾宪涛, 任学群. 分子流行病学研究与系统评价Meta分析 [M]. 北京: 中国协和医科大学出版社, 2018. [Zeng XT, Ren XQ. Molecular Epi-demiological Research and Systematic Review Meta-Analysis[M]. Beijing: Peking Union Medical College Press, 2018.]

16.张慧, 田旭, 卞薇, 等. JBI循证卫生保健中心简介[J]. 中国循证医学杂志, 2016, 16(12): 1477-1480. [Zhang H, Tian X, Bian W, et al. Brief introduction of the joanna briggs institute[J]. Chinese Journal of Evidence-Based Medicine, 2016, 16(12): 1477-1480.] DOI: 10.7507/1672-2531.20160221.

17.Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic re-views[J]. Syst Rev, 2012, 1: 2. DOI: 10.1186/2046-4053-1-2.

18.Porritt K, Gomersall J, Lockwood C. JBI's systematic reviews: study selection and critical appraisal[J]. Am J Nurs, 2014, 114(6): 47-52. DOI: 10.1097/01.NAJ.000045 0430.97383.64.

19.Munn Z, Tufanaru C, Aromataris E. JBI's systematic reviews: data extraction and synthesis[J]. Am J Nurs, 2014, 114(7): 49-54. DOI: 10.1097/01.NAJ.0000451683.66447.89.

20.Munn Z, Aromataris E, Tufanaru C, et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)[J]. Int J Evid Based Healthc, 2019, 17(1): 36-43. DOI: 10.1097/XEB.0000000000000152.

21.翁鸿, 王颖, 李柄辉, 等. 系统评价与Meta分析的类型及制作步骤[J]. 同济大学学报(医学版), 2019, 40(2): 248-253. [Weng H, Wang Y, Li BH, et al. Types and steps of systematic review and meta-analysis:a brief introduction[J]. Journal of Tongji University (Medical Sci-ence), 2019, 40(2): 248-253.] DOI: 10.16118/j.1008-0392.2019.02.022.

22.拜争刚, 赵坤, 刘丹, 等. 循证社会科学的推动者: Campbell协作网[J]. 中国循证医学杂志, 2018, 18(12): 1380-1385. [Bai ZG, Zhao K, Liu D, et al. Evidence-based social science promoter: the Campbell Collaboration[J]. Chinese Journal of Evidence-Based Medicine, 2018, 18(12): 1380-1385.] DOI: 10.7507/1672-2531.201807127.

23.李佩玲, 常健博, 许影, 等. 如何撰写Campbell系统评价[J]. 中国循证医学杂志, 2015, 15(5): 617-620. [Li PL, Chang JB, Xu Y, et al. How to perform the Campbell systematic review[J]. Chinese Journal of Evidence-Based Medicine, 2015, 15(5): 617-620.] DOI: 10.7507/1672-2531.20150102.

24.樊景春, 耿男, 拜争刚, 等. 环境证据协作网及环境治理系统评价指南简介[J]. 医学新知, 2020, 30(4): 279-284. [Fan JC, Geng N, Bai ZG, et al. Introduction of Collaboration for Environmental Evidence and guidelines and standards for evidence synthesis in environmental management[J]. New Medicine, 2020, 30(4): 279-284.] DOI: 10.12173/j.issn.1004-5511.2020.04.04.

25.Pieper D, Rombey T. Where to prospectively register a systematic review[J]. Syst Rev, 2022, 11(1): 8. DOI: 10.1186/s13643-021-01877-1.

26.Palepu A, Kendall C, Moher D. Open Medicine endorses PROSPERO[J]. Open medicine, 2011, 5(1): e65-6. https://pubmed.ncbi.nlm.nih.gov/22046223/.

27.Puljak L. Delays in publishing systematic review registrations in PROSPERO are hindering transparency and may lead to re-search waste[J]. BMJ Evid Based Med, 2021, 26(6): e4. DOI: 10.1136/bmjebm-2020-111474.

28.靳英辉, 吴世文, 拜争刚, 等. 系统评价与Meta分析的内涵及价值[J]. 同济大学学报(医学版), 2019, 40(1): 105-111. [Jin YH, Wu SW, Bai ZG, et al. Connotations and application of systematic review and meta-analysis: a briefly introduction[J]. Journal of Tongji University (Medical Science), 2019, 40(1): 105-111.] DOI: 10.16118/j.1008-0392.2019.01.020.

29.Chen Y, Guyatt GH, Munn Z, et al. Clinical practice guidelines registry: toward reducing duplication, improving collaboration, and increasing transparency[J]. Ann Intern Med, 2021, 174(5): 705-707. DOI: 10.7326/M20-7884.

30.习近平. 在科学家座谈会上的讲话 [N/OL]. 新华网, 2020-09-11 [2022-01-25]. http://www.xinhuanet.com/politics/leaders/2020-09/11/c_1126483997.htm.

31.王行环. 循证临床实践指南的研发与评价[M]. 北京: 中国协和医科大学出版社, 2016. [Wang XH. Methodology for Evidence-Based Clin-ical Practice Guidelines Development and Evaluation[M]. Beijing: Peking Union Medical College Press, 2016.]

32.王艳, 姚仁斌. 浅议国内应建立规范的Meta分析中文注册平台[J]. 中国传媒科技, 2021, (7): 94-96. [Wang Y, Yao RB. A brief discussion on the establishment of a standardized Chinese registration platform for Meta analysis in China[J]. Science & Technology for Chi-na's Mass Media, 2021, (7): 94-96.] DOI: 10.19483/j.cnki.11- 4653/n.2021.07.027.